Wyost

Wyost Patient Guide: How to Get Wyost at Low or No Cost

Wyost (denosumab-bbdz) is a biosimilar medication used to treat osteoporosis in postmenopausal women at high risk for fracture, increase bone mass in men with osteoporosis, and treat glucocorticoid-induced osteoporosis.[1][4] Sandoz offers the Sandoz One Source Patient Support Program and Sandoz Patient Assistance Program (SPA) to help eligible patients access Wyost at low or no cost through copay assistance, financial aid for uninsured/underinsured, and other support services.[1][2][4][5][7][8]

About Wyost and Why Assistance Matters

Wyost is a subcutaneous injection given every 6 months by a healthcare provider. It's a biosimilar to Prolia (denosumab), offering the same efficacy at potentially lower cost. Like Prolia, Wyost has the same Medicare Part B coverage – no prior authorization or step edits required, with WAC-based reimbursement.[2] However, high out-of-pocket costs can be a barrier. Sandoz programs bridge this gap, providing copay cards (as low as $0 for eligible commercially insured patients), free medication for uninsured/underinsured, benefit verification, prior auth help, and nurse support.[1][2][4][5]

Who Qualifies for Sandoz Wyost Assistance?

Copay Assistance (Commercially Insured)

Eligible if you have commercial insurance (not government programs). Patients may pay as little as $0. Invalid for:

• Medicare (Part B/D), Medicaid, Medigap, TRICARE, VA, DoD, or federal/state programs.
• Uninsured patients.
• Insurance covering 100% of drug cost.
• Non-covered products. Program credits toward deductibles/copays/coinsurance but can't be used for copay accumulators/maximizers.[2][4]

Patient Assistance Program (Uninsured/Underinsured)

For patients with limited or no insurance meeting income guidelines (specific FPL % not publicly disclosed; call to verify).[5][8] Sandoz Patient Assistance (SPA) provides free medication. Independent foundations may also help.[5]

Income Eligibility Breakdown

Specific income thresholds aren't publicly listed online, but programs target low-income patients. Contact Sandoz One Source for personalized eligibility.[8] Here's a general overview based on similar programs:

*Estimates for illustration; actual thresholds per Sandoz guidelines. No Medicare/Medicaid.[2][4][8]

Insurance Requirements

• Commercial insurance: Eligible for copay help ($0 possible).[2][4]
• Medicare Part B: Covers Wyost like Prolia; no copay assistance available.[2]
• Uninsured/underinsured: Qualify for free drug via SPA if income-eligible.[5][7][8]
• Government insurance: Ineligible for copay program.[2][4] Sandoz Case Managers assist with benefit verification, prior auths, appeals, billing/coding.[2][4]

Step-by-Step Application Process

1. Talk to your doctor: Confirm Wyost prescription. Download WYOST Enrollment and Prescription Form.[4][7]
2. Visit Sandoz One Source: Go to sandoz-onesource.com/wyost. Select "Patient" > "E-Consent (Patient Authorization)".[1]
3. Enroll online or download form:
   • Online: Complete digital enrollment.[1][4]
   • Download & fax: Fill form, fax to 1-833-671-1084.[2][4][7]
4. Provide info: Prescription, insurance details, income proof (if applying for PAP).[7][8]
5. Sign e-consent: Authorize Sandoz/SPA to transmit prescription and handle services.[1][7]
6. Call for help: 1-800-954-9128 – speak to Case Manager for guidance.[2][4]

HCP Portal offers injection tracking, text reminders.[2][4]

Timeline and Delivery

Processing time not specified; typically 2-4 weeks for PAP approvals (call to confirm). Once approved:

• Copay card: Instant access post-enrollment.
• Free medication: Shipped to doctor's office or pharmacy via SPA.[7]
• Delivery by Sandoz partners; nurse outreach available.[4] Track via HCP Portal.[2]

Biosimilar Alternatives if Denied

If ineligible for Wyost program, consider these denosumab biosimilars with similar Sandoz/Fresenius/Celltrion support:

• Jubbonti (denosumab-bbdz, Sandoz): Same program as Wyost.[2][3]
• Bomyntra (denosumab-bnht, Fresenius Kabi)
• Conexxence (denosumab-bnht, Fresenius Kabi)
• Stoboclo (denosumab-bmwo, Celltrion)
• Osenvelt (denosumab-bmwo, Celltrion) Discuss with doctor; many have parallel assistance.[biosimilarAlternatives]

If Denied: Next Steps

• Appeal with Case Manager help.[2][4]
• Apply to independent foundations.[5]
• Check general PAPs like RxAssist or NeedyMeds.
• Explore state programs.

Disclaimer

This guide is for informational purposes based on available sources as of 2026. Eligibility, terms subject to change. Sandoz reserves right to amend/revoke programs. Not medical/financial advice. Consult healthcare provider/ Sandoz (1-800-954-9128) for personalized info. Programs not for government insurance.[2][4][8] (Word count: 912)